Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
Nur Samsu,1 Setyawati Soeharto,2 Muhaimin Rifai,3 Achmad Rudijanto41Department of Internal Medicine, Division of Nephrology and Hypertension, Faculty of Medicine; 2Department of Pharmacology, Faculty of Medicine; 3Department of Biology, Faculty of Mathematics and Sciences; 4Department of Internal Me...
Enregistré dans:
Auteurs principaux: | Samsu N, Soeharto S, Rifai M, Rudijanto A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dfb10b83fb5e44e79a63eaa11fe96430 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Potential Role of Rosmarinic Acid and Sinensetin as α-Amylase Inhibitor: In Silico Study
par: Hazna Noor Meidinna, et autres
Publié: (2019) -
Rosmarinic Acid Delays Tomato Fruit Ripening by Regulating Ripening-Associated Traits
par: Changan Zhu, et autres
Publié: (2021) -
Rosmarinic acid ameliorates renal ischemia reperfusion damage in rats
par: Majid Tavafi, et autres
Publié: (2020) -
The Beneficial Effect of Rosmarinic Acid on Benzophenone-3-Induced Alterations in Human Skin Fibroblasts
par: Anna Galicka, et autres
Publié: (2021) -
Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches
par: Madureira AR, et autres
Publié: (2016)